Clinical evaluation of raja amirthathi chooranam (internal) and karappan ennai (external) for the managaement of balakarappan(atopic dermatitis) in children

Clinical evaluation of raja amirthathi chooranam (internal ) and karappan ennai (external) for the managaement of balakarappan in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035999

Enrollment

Registered

2021-08-27

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Raja amirthathi choornam (internal) Karappan ennai (external): Raja amirthathi choornam is given with water ,twice a day for 45 days Dosage 7 years - 350 gms 8 -12 years -500 gms Karapp

Eligibility

Inclusion criteria

Inclusion criteria: children with one or more of the following symptoms Itching Erythema Oedema Oozing Crusting and scaling Lichenified plaque

Exclusion criteria

Exclusion criteria: Psoriasis Scabies Photo dermatitis Fungal and parasitic skin infections Any other serious illness

Design outcomes

Primary

Measure	Time frame
Efficacy of the trial drug is measured by using EASI score and improvement in the clinical conditions will be observedTimepoint: 45 days	—

Secondary

Measure	Time frame
Reduction in the recurrence of the disease and improvement in the quality of life of childrenTimepoint: Before and after treatment	—

Countries

India

Contacts

Public ContactDr S Praveena

National institute of siddha

gvennils@gmail.com9789093986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026